The anesthetic ketamine has become increasingly popular as a treatment for people with severe depression that resists conventional therapies. Now, new research using zebrafish provides new insights into how it works.

From Florian Engert and colleagues at Janelia. Co-first authors Marc Duque Ramírez and Alex Chen. Read more at the Harvard Gazette.